High fracture risk, limited evidence: rethinking osteoporosis treatment in chronic kidney disease. Brampton JJ, Harris BHL, Fertleman MB, Koizia LJ, et al. Osteoporos Int 2026 Feb 5. doi: 10.1007/s00198-026-07890.

Read + Share

Amedeo Smart

Independent Medical Education

Brampton JJ, Harris BHL, Fertleman MB, Koizia LJ, et al. High fracture risk, limited evidence: rethinking osteoporosis treatment in chronic kidney disease. Osteoporos Int 2026 Feb 5. doi: 10.1007/s00198-026-07890.
PMID: 41642331